-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U1Naq4k2nBnploLDbb99C+mIkYqav5HK8xr6ISu2Jm9OVPB216sdtONHthsNy9O4 4y9yeD1vFx+DkvJXwlayXg== 0000000000-06-014309.txt : 20061016 0000000000-06-014309.hdr.sgml : 20061016 20060324155424 ACCESSION NUMBER: 0000000000-06-014309 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060324 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 PUBLIC REFERENCE ACCESSION NUMBER: 0001144204-05-033237 LETTER 1 filename1.txt Via Facsimile and U.S. Mail Mail Stop 6010 March 24, 2006 Ms. Rose C. Perri Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary Generex Biotechnology Corporation 33 Harbour Square, Suite 202 Toronto, Canada M5J 2G2 Re: Generex Biotechnology Corporation Form 10-K for Fiscal Year Ended July 31, 2005 Filed on October 31, 2005 File No. 000-25169 Dear Ms. Perri: We have completed our review of your Form 10-K and have no further comments at this time. Sincerely, Joseph J. Roesler Accounting Branch Chief ?? ?? ?? ?? Ms. Rose C. Perri Generex Biotechnology Corporation March 2, 2006 Page 3 -----END PRIVACY-ENHANCED MESSAGE-----